Synlett 2015; 26(18): 2553-2556
DOI: 10.1055/s-0034-1381048
letter
© Georg Thieme Verlag Stuttgart · New York

An Efficient Synthesis of Enantiopure (2R,3R)-β-Methoxytyrosine

Shi-Ming Fan
a   Department of Chemistry, College of Science, Yanbian University, 977 Gongyuan Road, Yanji 133002, P. R. of China   Email: lyjin@ybu.edu.cn
,
Xia Tian
b   State Key Laboratory Breeding Base-Hebei Province Laboratory of Molecular Chemistry for Drug, Hebei University of Science & Technology, 70 Yuhua Road, Shijiazhuang 050018, P. R. of China   Email: chlsx@hebust.edu.cn
,
Yi-Hua Yang
b   State Key Laboratory Breeding Base-Hebei Province Laboratory of Molecular Chemistry for Drug, Hebei University of Science & Technology, 70 Yuhua Road, Shijiazhuang 050018, P. R. of China   Email: chlsx@hebust.edu.cn
,
Long yi Jin*
a   Department of Chemistry, College of Science, Yanbian University, 977 Gongyuan Road, Yanji 133002, P. R. of China   Email: lyjin@ybu.edu.cn
,
Shou-xin Liu*
a   Department of Chemistry, College of Science, Yanbian University, 977 Gongyuan Road, Yanji 133002, P. R. of China   Email: lyjin@ybu.edu.cn
b   State Key Laboratory Breeding Base-Hebei Province Laboratory of Molecular Chemistry for Drug, Hebei University of Science & Technology, 70 Yuhua Road, Shijiazhuang 050018, P. R. of China   Email: chlsx@hebust.edu.cn
› Author Affiliations
Further Information

Publication History

Received: 18 May 2015

Accepted after revision: 21 June 2015

Publication Date:
01 September 2015 (online)


Abstract

Enantiopure (2R,3R)-β-methoxytyrosine was stereoselectively synthesized from ethyl 3-(4-hydroxyphenyl)-3-oxopropanoate protected by 2-methoxyethoxymethyl (MEM) (ee >98%). l-Aminoacylase-catalyzed resolution of the corresponding erythro-N-acetyl derivatives afforded (2S,3S)-(4-MEM)-β-methoxytyrosine (ee >99%). The conversion increased to 98% by optimizing the synthesis to yield enantiopure N-acetyl-(2R,3R)-(4-MEM)-methoxytyrosine. N-Acyl cleavage was accomplished under mild conditions.

Supporting Information

 
  • References and Notes

  • 1 Bagavananthem Andavan GS, Lemmens-Gruber R. Mar. Drugs 2010; 8: 810
  • 3 Martín MJ, Rodríguez-Acebes R, García-Ramos Y, Martínez V, Murcia C, Digón I, Marco I, Pelay-Gimeno M, Fernández R, Reyes F, Francesch AM, Munt S, Tulla-Puche J, Albericio F, Cuevas C. J. Am. Chem. Soc. 2014; 136: 6754
    • 4a Ford PW, Gustafson KR, McKee TC, Shigematsu N, Maurizi LK, Pannell LK, Williams DE, Dilip de Silva E, Lassota P, Allen TM, Van Soest R, Andersen RJ, Boyd MR. J. Am. Chem. Soc. 1999; 121: 5899
    • 4b Prasad P, Aalbersberg W, Feussner K.-D, Van Wagoner RM. Tetrahedron 2011; 67: 8529
  • 6 Tran TD, Pham NB, Fechner G, Zencak D, Vu HT, Hooper JN. A, Quinn RJ. J. Nat. Prod. 2012; 75: 2200
  • 7 Ratnayake AS, Bugni TS, Feng X, Harper MK, Skalicky JJ, Mohammed KA, Andjelic CD, Barrows LR, Ireland CM. J. Nat. Prod. 2006; 69: 1582
  • 9 Zampella A, D’Orsi R, Sepe V, Casapullo A, Monti MC, D’Auria MV. Org. Lett. 2005; 7: 3585
  • 10 Konno H, Aoyama S, Nosaka K, Akaji K. Synthesis 2007; 3666
  • 11 Fan S, Liu S, Zhang H, Liu Y, Yang Y, Jin L. Eur. J. Org. Chem. 2014; 5591
  • 12 Li J, Wang J, Liu S. Fine Chemicals 2012; 29: 787
  • 13 Chang YT, Hartung WH. J. Am. Chem. Soc. 1953; 75: 89
  • 14 Characterization Data for 4: white solid; mp 59–60 °C. 1H NMR (500 MHz, CDCl3): δ = 7.20 (d, J = 8.5 Hz, 2 H), 7.05 (d, J = 9.0 Hz, 2 H), 6.08 (d, J = 9.0 Hz, 1 H), 5.27 (s, 2 H), 4.92 (dd, J = 9.0, 4.5 Hz, 1 H), 4.55 (d, J = 4.5 Hz, 1 H), 4.12 (m, 2 H), 3.83 (m, 2 H), 3.56 (m, 2 H), 3.37 (s, 3 H), 3.21 (s, 3 H), 2.01 (s, 3 H), 1.16 (t, J = 7.0 Hz, 3 H). 13C NMR (125 MHz, CDCl3): δ = 169.9, 169.7, 157.4, 130.3, 128.0, 93.6, 83.1, 71.7, 67.8, 61.4, 59.1, 57.7, 57.1, 23.2, 14.0. HRMS: m/z [M + H]+ calcd for C18H28NO7: 370.1866; found: 370.1857.
  • 15 Burk MJ, Allen JG. J. Org. Chem. 1997; 62: 7054
  • 16 Akbaba Y, Türker Balaydın H, Göksu S, Şahin E, Menzek A. Helv. Chim. Acta 2010; 93: 1127
  • 17 Characterization Data for 8: white solid; [α]D 20 +6.1° (c = 0.2, MeOH). HPLC: column: Daicel Chem. Ind. Crownpak CR(+), mobile phase: MeOH–H2O, 1:7 at pH 1.0 (HClO4), 25 °C; flow rate = 0.4 mL/min, t R = 7.9 min. 1H NMR (500 MHz, CD3OD containing 1% TFA): δ = 7.17 (d, J = 8.5 Hz, 2 H), 6.82 (d, J = 8.5 Hz, 2 H), 4.80 (d, J = 4.0 Hz, 1 H), 4.28 (d, J = 4.0 Hz, 1 H), 3.34 (s, 3 H). 13C NMR (125 MHz, CD3OD containing 1% TFA): δ = 169.1, 159.4, 129.6, 125.8, 116.7, 81.4, 59.1, 57.4. HRMS: m/z [M + H]+ calcd for C10H14NO4: 212.0923; found: 212.0917.
  • 18 Aminoacylase Resolution: A solution of 4 (3.7 g, 10 mmol) in a mixture of EtOH (36 mL) and 1 N NaOH (10.0 mL) was stirred for 1.5 h at 0 °C. This was then concentrated under reduced pressure to 3 mL. Deionized H2O (84 mL) and 0.05 M CoCl2 (1.7 mL) were then added to the residue, and the pH of the solution was adjusted to 7.5 with 1 N HCl. The mixture was stirred at 40 °C. The l-aminoacylase (40 mg) was added three times at 12 h intervals to this magnetically stirred solution. The pH was maintained at 7.5 with 0.1 N NaOH, and the mixture was concentrated under reduced pressure to 10 mL. The residue was cooled to 0 °C and acidified with cold concentrated HCl to pH 1. It was then extracted with EtOAc (3 × 50 mL), and these extracts were washed with 2% HCl (2 × 30 mL), dried over anhyd Na2SO4, and concentrated to yield N-acetyl enantiomer 7 (1.5 g, 88%). The aqueous layer was adjusted to pH 6.5 with 4.0 N NaOH and concentrated until the volume reached 5 mL. The precipitated crystals were collected on a filter, washed with a small amount of H2O, and dried to give a tan solid 6 (1.06 g, 71%).